Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience.
McCall D, Alqahtani S, Budak M, Sheikh I, Fan AE, Ramakrishnan R, Nunez C, Roth M, Garcia MB, Gibson A, Daver N, Garces S, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garcia-Manero G, Cuglievan B, Kadia T. McCall D, et al. Among authors: montalban bravo g. Cancers (Basel). 2024 Nov 20;16(22):3886. doi: 10.3390/cancers16223886. Cancers (Basel). 2024. PMID: 39594839 Free PMC article.
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.
Jen WY, Marvin-Peek J, Kantarjian HM, Alvarado Y, Borthakur G, Jabbour E, Wierda W, Kadia TM, Daver NG, DiNardo CD, Short NJ, Jain N, Ferrajoli A, Kornblau S, Yilmaz M, Ohanian M, McCue D, Burger J, Hammond D, Patel K, Issa GC, Pemmaraju N, Sasaki K, Maiti A, Abbas HA, Chien K, Takahashi K, Haddad F, Bose P, Masarova L, Montalban-Bravo G, Swaminathan M, Brandt M, Pierce S, Garcia-Manero G, Ravandi F. Jen WY, et al. Among authors: montalban bravo g. Cancer. 2024 Nov 25. doi: 10.1002/cncr.35662. Online ahead of print. Cancer. 2024. PMID: 39584789
A phase II trial of ipilimumab, nivolumab, or ipilimumab and nivolumab with or without azacitidine in relapsed or refractory myelodysplastic neoplasms.
Bouligny IM, Montalban-Bravo G, Sasaki K, Daver N, Jabbour E, Alvarado Y, DiNardo CD, Ravandi F, Borthakur G, Pemmaraju N, Kadia T, Masarova L, Takahashi K, Andreeff M, Bazinet A, Yang H, Kanagal R, Pierce S, Meyer M, Huang X, Garcia-Manero G. Bouligny IM, et al. Among authors: montalban bravo g. Leukemia. 2024 Nov 17. doi: 10.1038/s41375-024-02457-7. Online ahead of print. Leukemia. 2024. PMID: 39551874 No abstract available.
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis.
Urrutia S, Kantarjian HM, Ravandi-Kashani F, Bueso-Ramos C, Kanagal-Shamanna R, Jabbour E, Montalban-Bravo G, Short NJ, Daver N, Borthakur G, Dinardo CD, Kadia TM, Masarova L, Bose P, Pemmaraju N, Garcia-Manero G, Sasaki K. Urrutia S, et al. Among authors: montalban bravo g. J Hematol Oncol. 2024 Nov 15;17(1):112. doi: 10.1186/s13045-024-01630-w. J Hematol Oncol. 2024. PMID: 39548557 Free PMC article.
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial.
Rodriguez-Sevilla JJ, Adema V, Chien KS, Loghavi S, Ma F, Yang H, Montalban-Bravo G, Huang X, Calvo X, Joseph J, Bodden K, Garcia-Manero G, Colla S. Rodriguez-Sevilla JJ, et al. Among authors: montalban bravo g. Nat Commun. 2024 Nov 13;15(1):9840. doi: 10.1038/s41467-024-54290-2. Nat Commun. 2024. PMID: 39537648 Free PMC article. Clinical Trial.
Causes of death in patients with myelodysplastic syndrome and spliceosome mutations.
Kontoyiannis PD, Peddireddy AS, Sasaki K, Chien K, Senapati J, Montalban-Bravo G, DiNardo C, Borthakur G, Kanagal-Shamanna R, Bueso-Ramos C, Pierce S, Kantarjian H, Garcia-Manero G, Urrutia S. Kontoyiannis PD, et al. Among authors: montalban bravo g. Leuk Res. 2024 Dec;147:107612. doi: 10.1016/j.leukres.2024.107612. Epub 2024 Nov 6. Leuk Res. 2024. PMID: 39536685 No abstract available.
Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study.
Tremblay D, Csizmar C, DiNardo CD, Ball S, Rippel N, Hammond D, Kadia TM, Ravandi F, Chien K, Van Hyfte G, Mazumdar M, Saliba A, Mangaonkar A, Lasho T, Al-Kali A, Kremyanskaya M, Feld J, Silverman LR, Komrokji R, Mascarenhas J, Padron E, Garcia-Manero G, Sallman DA, Patnaik MM, Montalban-Bravo G. Tremblay D, et al. Among authors: montalban bravo g. Leukemia. 2024 Nov 12. doi: 10.1038/s41375-024-02466-6. Online ahead of print. Leukemia. 2024. PMID: 39533069 No abstract available.
A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure.
Chien KS, Rodriguez-Sevilla JJ, Alvarado Y, Montalban-Bravo G, Hammond DE, Swaminathan M, Bazinet A, Kimberley J, Bodden K, Schneider H, Dong XQ, Pierce SA, Huang X, Jabbour EJ, Kantarjian HM, Garcia-Manero G. Chien KS, et al. Among authors: montalban bravo g. Leuk Res. 2024 Dec;147:107602. doi: 10.1016/j.leukres.2024.107602. Epub 2024 Oct 22. Leuk Res. 2024. PMID: 39461095 No abstract available.
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin.
Senapati J, Jabbour E, Short NJ, Jain N, Haddad F, Bathala T, Kovalenko I, Bidikian A, Ravandi F, Khouri I, Kadia TM, Garris R, Montalban Bravo G, Chien K, Shpall E, Kebriaei P, Kantarjian HM. Senapati J, et al. Among authors: montalban bravo g. Blood Cancer J. 2024 Aug 7;14(1):129. doi: 10.1038/s41408-024-01098-4. Blood Cancer J. 2024. PMID: 39112504 Free PMC article. No abstract available.
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL.
Kantarjian H, Short NJ, Haddad FG, Jain N, Huang X, Montalban-Bravo G, Kanagal-Shamanna R, Kadia TM, Daver N, Chien K, Alvarado Y, Garcia-Manero G, Issa GC, Garris R, Nasnas C, Nasr L, Ravandi F, Jabbour E. Kantarjian H, et al. Among authors: montalban bravo g. J Clin Oncol. 2024 Jul 19:JCO2400272. doi: 10.1200/JCO.24.00272. Online ahead of print. J Clin Oncol. 2024. PMID: 39028925
131 results